Area of Residence and Socioeconomic Factors Reduce Access to Biologics for Rheumatoid Arthritis Patients in Romania

Abstract

Introduction The study aimed to evaluate the influence of socioeconomic factors on rheumatoid arthritis (RA) patients' access to biologics in Romania. Method Cross-sectional data were collected in January 2014 from the Romanian Registry of Rheumatic Diseases (RRRD) comprising all RA patients on biologics from 42 Romanian counties. “Territorial” access to biologics was defined by patients receiving biologics in their home county. A county was “equitable” if <25% of RA patients received biologics outside it. Results The RRRD included 4507 RA patients aged 56.7 ± 12.1 years, with a disease duration of 12.1 ± 8.3 years. Urban dwellers (67.8%) had a significantly higher prevalence of territorial biologic access than rural dwellers (83.1% compared to 74.1%; p < 0.001). Gross domestic product (GDP) in 1000 €/capita/county (odds ratio (OR) = 1.224) and number of physicians/1000 inhabitants/county (OR = 2.198) predict territorial access to biologics and also predict the number of territorially treated RA patients. Inequitable counties exhibited significantly lower socioeconomic indicators than equitable counties. Conclusion In Romania, RA patients' access to biologics varies significantly between counties. Urban dwellers and patients living in counties/regions with high living standards are more likely to receive biologics locally than those living in more deprived areas.

Accessibility to biologics and its impact on disease activity and quality of life in patients with rheumatoid arthritis in Kuwait

“…Other factors such as the area of residence and low education class negatively impacted access to biologic agents. Moreover, elderly patients had less access to these drugs in other studies [ 23 , 24 ].…”

Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural–urban gap and north–south gradient

“…In line with the present study, the frequency of adherent patients was comparable and rural residence was among the most important factors associated with non-adherence to medications in Egyptian RA cases [ 4 ]. Similarly, in Romania, urban RA patients had a significantly higher frequency of biologic access than those from rural areas [ 35 ]. Rural clinic location was associated with lower use of biologics suggesting a possible prescription bias or patient preferences due to convenience [ 36 ].…”

Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?

“…The authors concluded that this warranted further investigation as, despite universal access to treatment in Sweden, different counties seemed to have different initiation thresholds, perhaps reflecting different treatment traditions among rheumatologists as well as county-specific economic considerations. Regional differences were also found in Romania, where urban dwellers and those living in regions with higher living standards were more likely to receive biologics than those living in more deprived areas (Codreanu et al, 2018). This is unlikely to be accounted for by differences in patient incomes, as co-payments for biologics are not required in Romania (Kawalec et al, 2017).…”